STELLA, LEONARDO
 Distribuzione geografica
Continente #
AS - Asia 351
EU - Europa 229
NA - Nord America 190
AF - Africa 45
SA - Sud America 37
OC - Oceania 3
Totale 855
Nazione #
US - Stati Uniti d'America 173
SG - Singapore 96
IT - Italia 95
CN - Cina 84
DE - Germania 68
VN - Vietnam 63
EG - Egitto 35
IN - India 33
HK - Hong Kong 28
BR - Brasile 24
FR - Francia 22
MX - Messico 13
JP - Giappone 11
NL - Olanda 10
PL - Polonia 10
GB - Regno Unito 8
BD - Bangladesh 5
PK - Pakistan 5
IQ - Iraq 4
RO - Romania 4
TR - Turchia 4
AU - Australia 3
CO - Colombia 3
EC - Ecuador 3
HU - Ungheria 3
KR - Corea 3
UA - Ucraina 3
ZA - Sudafrica 3
AR - Argentina 2
CA - Canada 2
DZ - Algeria 2
ID - Indonesia 2
IE - Irlanda 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 855
Città #
Frankfurt am Main 62
Ashburn 47
San Jose 47
Singapore 31
Hong Kong 28
Ho Chi Minh City 21
Al Mansurah 20
Kolkata 15
Cairo 13
Hanoi 13
Hillsboro 12
Tokyo 10
Rome 9
Boardman 8
Beijing 7
Warsaw 7
Amsterdam 6
Mexico City 6
New York 6
Orem 6
Los Angeles 5
Verona 5
Chennai 4
Indore 4
Limburg an der Lahn 4
Milan 4
Naples 4
Bari 3
Bologna 3
Budapest 3
Da Nang 3
Phủ Lý 3
Bishkek 2
Brisbane 2
Bắc Giang 2
Bắc Ninh 2
Can Tho 2
Faisalabad 2
Karachi 2
Oakland 2
Portsmouth 2
São Paulo 2
Taboão da Serra 2
Toronto 2
Wroclaw 2
Abu Dhabi 1
Aga 1
Ahmedabad 1
Alto Araguaia 1
Amman 1
Apizaco 1
Bacau 1
Baghdad 1
Bahía Blanca 1
Baku 1
Bangkok 1
Banjar Badung 1
Barranquilla 1
Belford Roxo 1
Bogotá 1
Botoșani 1
Brescia 1
Bucharest 1
Buffalo 1
Bursa 1
Campo Belo 1
Cape Town 1
Caracas 1
Casablanca 1
Chandigarh 1
Changsha 1
Chiclayo 1
Cochabamba 1
Colima 1
Columbus 1
Council Bluffs 1
Cubatão 1
Dallas 1
Danbury 1
Dikirnis 1
Duhok 1
Durban 1
Eagleville 1
Florence 1
Fortaleza 1
Fukuoka 1
Galway 1
Genoa 1
Giugliano in Campania 1
Glenrothes 1
Guadalajara 1
Guarujá 1
Guarulhos 1
Guayaquil 1
Gwangjin-gu 1
Göppingen 1
Haiphong 1
Irecê 1
Istanbul 1
Jakarta 1
Totale 500
Nome #
PO4-03-YI Efficacy and safety of atezoliumab/bevacizumab for hepatocellular carcinoma in a real-world prospective cohort: a 2024 update 43
PO6-11 Statins in patients with advanced HCC treated with atezolizumab/bevacizumab: a propensity score-matched cohort analysis from ARTE an Italian prospective multicentric dataset 42
PO5-12-YI Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab-Bevacizumab for hepatocellular carcinoma 42
COVID-19 atypical Parsonage-Turner syndrome: a case report 36
PP0819 HEPATITIS C TREATMENT IMPROVES ONCOLOGIC OUTCOMES IN PATIENTS RECEIVING ATEZOLIZUMAB PLUS BEVACIZUMAB 33
PO5-18-YI Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma 32
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 27
PO3-23-YI The changing epidemiology of patients with HCC receiving a first-line systemic therapy: insights from ARPES and ARTE databases (2008- 2024) 27
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis 22
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 21
OP034 LIVER DECOMPENSATION AS A NEW OUTCOME AND PROGNOSTIC INDICATOR IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB PLUS BEVACIZUMAB: A REAL-LIFE MULTICENTER STUDY 20
Manuale di malattie infettive e microbiologia. SSM 2026 20
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 19
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 18
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores 17
OC.03.3 COMPARATIVE ANALYSIS OF ATEZOBEV’S THERAPEUTIC EFFICACY IN ADVANCED HEPATOCELLULAR CARCINOMA AMONG NON-CIRRHOTIC PATIENTS: FINDINGS FROM A RETROSPECTIVE MULTICENTER STUDY 17
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 16
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 16
Assessment of neurological manifestations in hospitalized patients with COVID‐19 16
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 15
Persistent Symptoms in Patients After Acute COVID-19 15
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients 15
Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management 15
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 14
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 14
Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma 14
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment 14
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 14
Malnutrition in COVID-19 survivors: prevalence and risk factors 14
Can AtezoBev be a safe and effective option for treating hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicenter real-world study 14
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease 13
Manuale di malattie infettive e microbiologia. Concorso Nazionale SSM 13
Liver cirrhosis in the Emergency Department: a change of paradigm in DAAs era 13
THU-492 Prognostic significance of liver decompensation, liver function and portal hypertension in cirrhotic patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 12
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers 12
Intestinal Inflammation and Permeability in Patients Recovered from SARS-CoV-2 Infection 12
COVID-19 and intestinal inflammation: Role of fecal calprotectin 12
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab 12
Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results 11
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive 11
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study 11
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research 11
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 11
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab 11
Heparanase-1 and MMPs in Covid-19 and non-Covid-19 pneumonia 11
Neuropsychological Measures of Long COVID-19 Fog in Older Subjects 10
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection 10
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors 10
The diagnosis of neglected tropical diseases (NTDs) in Italy: reply 9
Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice 9
PO7-09-YI Does AtezoBev present as a safe and efficacious treatment option for hepatocellular carcinoma in patients with Child-Pugh B cirrhosis? A retrospective multicentric real-world study 9
Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients 8
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 7
Residual respiratory impairment after COVID-19 pneumonia 7
Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000–2015) 7
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 6
Neuropsychological measures of post-COVID-19 cognitive status 6
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 6
Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings 5
Totale 927
Categoria #
all - tutte 2.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026927 0 0 0 0 266 121 67 158 129 186 0 0
Totale 927